NDTP Stock Overview
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NDT Pharmaceuticals Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.23 |
| 52 Week High | US$1.00 |
| 52 Week Low | US$0.001 |
| Beta | 0 |
| 1 Month Change | -42.50% |
| 3 Month Change | 130.00% |
| 1 Year Change | 130.00% |
| 3 Year Change | -93.52% |
| 5 Year Change | 6.98% |
| Change since IPO | -99.65% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| NDTP | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 3.3% |
| 1Y | 130.0% | 12.0% | 25.0% |
Return vs Industry: NDTP exceeded the US Pharmaceuticals industry which returned 12% over the past year.
Return vs Market: NDTP exceeded the US Market which returned 25% over the past year.
Price Volatility
| NDTP volatility | |
|---|---|
| NDTP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NDTP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NDTP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Jim Hovis | www.ndtpharma.com |
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
NDT Pharmaceuticals Inc. Fundamentals Summary
| NDTP fundamental statistics | |
|---|---|
| Market cap | US$109.69k |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs NDTP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NDTP income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did NDTP perform over the long term?
See historical performance and comparison